The scientific skills of Lyon’s experts in the fields of vaccines and certain cancers, such as sarcomas and lymphomas, are recognized world-wide.
The Lyonbiopôle world competitiveness cluster is undergoing rapid growth through the IRT (Institute for Technological Research) project and activities of world leaders Sanofi Pasteur, bioMérieux, Genzyme, Merck Serono, etc.
Lyon is also a recognized center for university education and is France’s first city for education in life sciences.
Lyon is also in a strong position in the Pharma Biotech sector, at the top level of one of the biggest European pharmacy and biotechnology markets. With almost 100,000 jobs in the health sector, Lyon is one of the ten biggest health and biotech markets in Europe: an opportunity for all business developers in the life sciences field.
Write to us or call us at
+ 33 (0)4 72 40 57 50
Lyonbiopole is the gateway for healthcare innovation in Rhône-Alpes. Thanks to Lyonbiopôle, Lyon has become a world center for excellence in diagnostics, vaccines, oncology, neurology, and medical equipment. Its aim is to support the emergence and developement of innovative technologies, products and services for a more personalized medicine to the patient’s benefit, by encouraging closer ties between industry and university research departments.
The Hospices Civils de Lyon, a public institution, is the second University Hospital Centre (CHU) in France. A real multidisciplinary skill center, it has a large pool of human, technical and logistical resources in order to carry out care, teaching, medical research and innovation, prevention and health education.
The Hospices Civils group includes 14 multidisciplinary and specialist institutions and more than 22,000 professionals.
Infectiology, immunology and vaccines in Lyon
The field of infectiology encompasses all the techniques used for research into infectious diseases. Such diseases may be passed on through micro-organisms like viruses or bacteria and therefore bring the threat of pandemics. The skills of talented professionals in Lyon play an active role in advancing research into infectious diseases. Thanks to the presence of leading world organizations in the infectiology sector, Lyon offers a dynamic platform which guarantees that scientific projects can bear fruit.
Institut Bioaster, a joint project between Lyonbiopôle and the Institut Pasteur, the Institut BIOASTER offers an innovative approach in R&D based on integration of the different scientific and technological disciplines. The structure therefore develops a completely new model of public/private partnerships on the basis of an integrated and interdisciplinary R&D approach which aims to promote innovation in the study and treatment of infectious diseases.
Born of the cooperation between the Institut Pasteur and INSERM, the Jean Mérieux bio-safety level 4 laboratory is one of the pillars of the pharmaceutical sector in Lyon. This center dedicates its research to the fight against infectious diseases by working with viruses and bacteria that are not very well-known and dangerous. It is classed at bio-safety level 4, the highest security level, to ensure that there is no risk of outside infection.
AcCInov, a 6,500 sq. meter innovation platform in Lyon-Gerland is part of Lyon’s Lyonbiopôle policy of infrastructure development to support innovation.
The aim for the medium term is to cover all the links in the innovation chain in anticipation of industrial and commercial developments. The area under focus is new therapies, such as vaccines, diagnostic tests or therapeutic molecules, in the main fields of infectious diseases and cancers.
The Centre d’Infectiologie (Infectiology Center) hosts teams and R&D projects (diagnostics, vaccines, administrative systems, new therapies) and other ideas that are currently being developed. The center is also at the head of a network of European research programs and offers a synergistic work place for active participation and interaction.
Oncology in Lyon
Oncology is the medical speciality dedicated to the diagnosis and treatment of cancers and is pushing forward with research against cancer. With 27,000 new cases of cancer treated every year, the Rhône-Alpes region is France’s second-largest cancer research hub with 1,700 scientists and a number of prestigious organizations.
CLARA is a cancer research cluster specialized in oncology: it aims to bring together the academic, clinical and industrial spheres around innovative projects with strong potential. The overall aim is twofold: to ensure that breakthroughs are quickly transferred to patients and to support research.
The Centre Léon Bérard, is a hospital that has become a reference in oncology and is also a renowned research center offering excellent quality of care and the latest technological developments. More than 25,000 patients are treated there each year by 1,500 professionals.
ELI, the Institut Européen du Lymphome, (European Lymphoma Institute) brings together the best European lymphoma specialists and is dedicated to research training and education around this disease. The work of the institute has led to the creation of the first European exchange, collaboration and coordination network on lymphoma. Studies carried out at ELI will also contribute to standardization of regulatory texts within the heart of the European Union.
The oncology centre Léon Bérard
Neurosciences in Lyon
Neuroscience covers all the techniques that can be used to analyze and understand the nervous system and how it functions. Scientific studies allow the nervous system to be observed at a molecular level, which requires cutting-edge imaging equipment. The region is one of the rare clusters in Europe that covers all sectors of the neurology and cognitive science fields, with outstanding potential in neuro-imaging. The region hosts a comprehensive multimodal imaging platform with ESFR medical beamlines, synchrotron or positron imaging, a functional MRI imaging device, and encephalography devices (MEG). Research in the neuroscience field relies on:
Neurocampus, European research cluster for neuro-degenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, epilepsy, and schizophrenia, is the largest neurosurgical center in Europe (4,000 procedures per year).
The Neurocampus technical platform is located on a 100-hectare site which will soon include another 6,000 sq. meters of infrastructure, thus completing this already highly active cluster (1,600 beds in neurology and psychiatry, 500 professionals dedicated to neuroscientific research).
Sensory, motor, cognitive and psychic handicaps represent a major public health challenge on a national scale. Every year in France, more than 50% of those who suffer strokes (70,000 cases annually) are left with severe neurological deficiencies, most often relating to motor or sensory-motor impairments.
In 2007 the government decided to improve French units and medical services in this sector by encouraging higher-level research and care in France, which is recognized as one of the world’s foremost countries in this field. The Neurodis project was chosen to become a thematic research and care center founded through a scientific research foundation set up in August 2007.
The primary objective of the Neurodis Foundation is to attract top French or foreign researchers around its priority research themes. The foundation is France’s most important center outside the Paris region in terms of research and hospital personnel working in neurosciences, with more than 800 people, including 400 researchers and clinicians.
The CESAME Institute was officially opened in 2013 with the first working platform for intracerebral signals. The CESAME Institute, dedicated to brain functions and mental health, is part of the Neurodis foundation and officially launched is work at the beginning of the year with five technological platforms. The platform for intracerebral signals is therefore fully operational at the Lyon Hospital of Neurology.
Pierre Wertheimer Hospital
The Pierre Wertheimer Hospital of Neurology and Neurosurgery in Lyon is dedicated to neurological diseases. It brings together different neurological, neurosurgical and investigative services under one roof and won first place in the Mag2Lyon honor’s list for surgical centers in the Rhône region in May 2013
Nutrition and health
The Rhône-Alpes Center for Research into Human Nutrition (CRNH), the Bullukian Foundation, the Mérieux Institute, the Paul Bocuse Institute, the CarMeN laboratory, Nutrisens, Roquette and the SEB group have together made a commitment in creating the Centre Européen pour la Nutrition et la Santé (European Center for Nutrition and Health or CENS).
Based in Lyon, CENS aims to coordinate the main global research bodies as well as industrial players in the food-processing and pharmaceutical sectors in order to find scientific answers to nutrition-related health challenges.
Created in Lyon in January 2011, CarMeN is a biomedical research laboratory in the field of cardiovascular disease, metabolism, diabetes and nutrition. A real center of excellence which brings together the main research players in these fields in Lyon, CarMeN is currently composed of 5 research teams of 160 people.
Lyon is a city that brings together all the technologies of identification and validation of biomarkers. It is also where one of the world leaders in biomarkers, bioMérieux, was created.
Do you have a medical research project in France? Aderly can help you to succeed with your business, research or partnership projects in Lyon… Contact us !